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Abstract 
BACKGROUND: Human amniotic fluid-derived stem cells (hAF-MSCs) have a high proliferative capacity and 
osteogenic differentiation potential in vitro. The combination of hAF-MSCs with three-dimensional (3D) scaffold 
has a promising therapeutic potential in bone tissue engineering and regenerative medicine. Selection of an 
appropriate scaffold material has a crucial role in a cell supporting and osteoinductivity to induce new bone 
formation in vivo. 
AIM: This study aimed to investigate and evaluate the osteogenic potential of the 2
nd
-trimester hAF-MSCs in 
combination with the 3D scaffold, 30% Nano-hydroxyapatite chitosan, as a therapeutic application for bone 
healing in the induced tibia defect in the rabbit. 
SUBJECT AND METHODS: hAF-MSCs proliferation and culture expansion was done in vitro, and osteogenic 
differentiation characterisation was performed by Alizarin Red staining after 14 & 28 days. Expression of the 
surface markers of hAF-MSCs was assessed using Flow Cytometer with the following fluorescein-labelled 
antibodies: CD34-PE, CD73-APC, CD90-FITC, and HLA-DR-FITC. Ten rabbits were used as an animal model 
with an induced defect in the tibia to evaluate the therapeutic potential of osteogenic differentiation of hAF-MSCs 
seeded on 3D scaffold, 30% Nano-hydroxyapatite chitosan. The osteogenic differentiated hAF-MSCs/scaffold 
composite system applied and fitted in the defect region and non-seeded scaffold was used as control. The 
histopathological investigation was performed at 2, 3, & 4 weeks post-transplantation and scanning electron 
microscope (SEM) was assessed at 2 & 4 weeks post-transplantation to evaluate the bone healing potential in the 
rabbit tibia defect. 
RESULTS: Culture and expansion of 2
nd
-trimester hAF-MSCs presented high proliferative and osteogenic 
potential in vitro. Histopathological examination for the transplanted hAF-MSCs seeded on the 3D scaffold, 30% 
Nano-hydroxyapatite chitosan, demonstrated new bone formation in the defect site at 2 & 3 weeks post-
transplantation as compared to the control (non-seeded scaffold). Interestingly, the scaffold accelerated the 
osteogenic differentiation of AF-MSCs and showed complete bone healing of the defect site as compared to the 
control (non-seeded scaffold) at 4 weeks post-transplantation. Furthermore, the SEM analysis confirmed these 
findings.  
CONCLUSION: The combination of the 2
nd
-trimester hAF-MSCs and 3D scaffold, 30% Nano-hydroxyapatite 
chitosan, have a therapeutic perspective for large bone defect and could be used effectively in bone tissue 
engineering and regenerative medicine. 
 
 
 
Introduction 
 
Human amniotic fluid stem cells (hAF-MSCs) 
derived from the second trimester are of particular 
importance as a source of a multipotent fetal stem cell 
and characteristically as a rich source of fetal 
progenitor cells including osteoblasts. Successful 
differentiation into osteogenic stem cells in vitro 
proposes their crucial role in regenerative medicine 
and bone regeneration [1].  
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Amniotic mesenchymal stem cells (AF-MSCs) 
have been used in animal models as a pre-clinical 
application. AF-MSCs have been applied on critically 
sized femoral defects of nude rat in combination with 
biomaterial scaffold and showed bone formation in rat 
femoral defect [2]. 
In contrast to embryonic stem cells, 
undifferentiated AF-MSCs propagate widely without 
inducing tumour [3]. Unlike adult-derived stem cells, 
the AF-MSCs cell lines propagated up to 250 
population doublings retained long telomeres and a 
normal chromosomal karyotype [3]. Human amniotic 
fluid-derived stem cells (hAF-MSCs) are extensively 
multipotent and have been induced to differentiate into 
cell types representing each embryonic germ layer, 
including cells of osteogenic, adipogenic, 
chondrogenic, myogenic, endothelial, neuronal, and 
hepatic lineages [3-6]. 
To preserve and retain the physiological 
function and microstructure of the defected bones, 
regenerative medicine was explored very extensively 
during the last decades. Novel treatment techniques 
include utilising of nanocomposite scaffolds and 
sophisticated carriers for the targeting and delivery of 
bioactive molecules, mesenchymal stem cells and/or 
growth factors, providing both the structural exactness 
and the biochemical information to cells when they are 
differentiated into a particular type of tissue [7]. 
 Nano-hydroxyapatite (HA) is considered as 
the most inorganic mineral in human bone tissue, 
therefore, HA artificial conformable materials are 
largely employed in the curing of bone defects 
originated by traffic accidents, trauma and bone 
disease [8-10]. In the bone defects remediation, some 
problems are expected to take place, such as low rate 
bone healing. The slower healing rate is especially 
recognised for patients with metabolic bone disorders 
and local osteoporosis [11].  
 Despite the magnificent role done by HA, stile 
it poses some drawbacks when it is used alone such 
as mechanical failure in load-bearing sites. In addition 
to that, the well-known composition of natural bone is 
considered as a composite material. This composite is 
made of inorganic (HA) and organic (collagen of type 
(I)) materials. Therefore, many of studies discussed 
the concept of the incorporation of the inorganic 
materials within the biopolymer matrix to form a 
composite material mimicking the microstructure of 
the bone [9, 12, 13].    
 Accordingly, nanocomposite scaffolds 
consisting of biodegradable polymers and/or ceramics 
consolidate the beneficial peculiarities of both 
materials. The effective carrier scaffolds can maintain 
their microstructure, physicochemical and 
physicomechanical properties at the implantation site 
[14]. Chitosan (C) is considered as a suitable 
polysaccharide for the fabrication of 3D scaffolds due 
to its impressive properties, such as biodegradability, 
biocompatibility, non-toxicity and bio-functionality [15].  
The pre-clinical application of combined Stem 
cell technology with 3D biodegradable and 
nanostructure scaffold is a new trend of therapy in 
tissue engineering and bone repair, which is going to 
be investigated, evaluated and applied in this study. 
Human AF-MSCs have the advantage of being a 
versatile precursor cell with great expansion 
capability. However, few studies have reported 
research results related to Nano-
hydroxyapatite/chitosan (HA/C) scaffolds combined 
with hAF-MSCs in both in vitro and in vivo. Therefore, 
the aim of this study was directed to investigate the 
effect of the combination of 2
nd
-trimester hAF-MSCs 
with chitosan polymer scaffold contain 30% of HA (
W
/W 
%) in the treatment of bone defect assessment. 
 
 
Subjects and Methods 
 
Second-trimester amniotic fluid samples 
(collected between the 14
th
 and 18
th
 weeks of 
gestation) were obtained by amniocentesis from six 
women, three samples only (n = 3) were successfully 
isolated. The age range was between 24 to 36 years 
old. The Ethics Committee of the National Research 
Centre, Cairo, Egypt, approved the study protocol and 
all participants gave informed consent. 
 
 Isolation of Mesenchymal stem cells  
Mesenchymal stem cells were isolated from 
the collected amniotic fluid was done by centrifugation 
and pelleting of cells [3]. Subsequently, the cells were 
cultured in alpha minimal essential medium (α-MEM; 
Gibco BRL, Life Technologies B.V., Breda, 
Netherlands) containing 20% fetal bovine serum 
(FBS; Gibco ERL), 1% glutamax (Invitrogen), 100 
U/ml penicillin (Gibco ERL), and 100 U/ml 
streptomycin (Gibco ERL) and 4 ng/ml basic fibroblast 
growth factor (bFGF; Sigma) and incubated at 37°C 
under standard conditions with 5% CO2.  
 
 Culture, expansion and proliferation of 
 hAF-MSCs  
These steps were maintained in regular 
proliferation media to reach about 80% confluence, 
and then cells were passage and reseed. Manual 
scraping technique using cell scraper (Corning 
incorporated, Costar, Mexico) and collection of the 
cells, followed by centrifugation and re-suspension in 
regular proliferation media then re-seeding of cells in 
culture plates. Human AF-MSCs proliferation was 
done at 70% confluence of the 3
rd
 passage and were 
used for osteogenic differentiation by exchanging the 
culture media into Dulbecco's Modified Eagle's 
Medium (DMEM) containing 20% FBS, 50 mmol/l L-
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ascorbic acid 2-phosphate,10 mmol/l β-glycerol 
phosphate and 0.1 mmol/l dexamethasone as well as 
100 µg/ml penicillin/ streptomycin and 1% glutamax 
[16]. A comparable control culture (MSCs in 
proliferation media) was made for each sample. Two 
similar sets that differ in incubation time were 
simultaneously generated; one set (plates in 
differentiation media and control plates) was 
maintained in corresponding culture media for 14 days 
before passed into characterisation protocols. The 
second set; same kind of plates retained in its culture 
media for 29 days before characterisation. 
 
 Osteogenic differentiation characterisation 
This step was done using Alizarin Red 
staining for the detection of mineralised nodules 
developed in the differentiated cultures. In briefly, 
plates were washed three times with PBS and fixed in 
70% ethanol at room temperature for an hour, washed 
with dH2O before adding  2% Alizarin Red (pH 4.2). 
The plates were incubated at 37ºC for an hour with 
gentle shaking. Plates were washed with dH2O until 
the dye’s colour disappears. Carefully aspirate dH2O, 
wash the plates with PBS and add enough dH2O to 
cover the cellular monolayer to be ready for image 
capture by inverted microscope [17]. 
 
 Expression of the surface markers in AF-
 MSCs  
At the third passage (P3), AF-MSCs were 
assessed using Flow Cytometer, fluorescein-activated 
cell sorting (FACS) Calibur (BD Biosciences, USA). 
Cells were trypsinised (0.25% trypsin and 0.01% 
EDTA; w/v), washed twice with PBS supplemented 
with 0.5% Bovine Serum Albumin (BSA; Sigma-
Aldrich, Saint Louis, MO, USA), and resuspended in 
PBS at a concentration of 2×10
5
cells/20µl. 
Subsequently, the labelled cells were incubated with 
10µl of the following fluorescein-labelled antibodies, 
CD34-PE, CD73-APC, CD90-FITC, and HLA-DR-
FITC (BD Biosciences, USA) in dark place for 30 min 
at room temperature. Isotype-matched controls were 
performed for every analysis for the evaluation of 
possible nonspecific staining and autofluorescence 
[18]. 
Flow cytometry analysis operation started, and 
then a single colour immunofluorescence protocol was 
defined. A gate was set to include the population of 
interest, followed by running samples and 10.000 
events were collected. Data analysis was executed to 
determine percentage positivity for the antibody [18]. 
Detailed immunophenotype analysis was carried out 
by flow cytometry using relevant markers. The 
cultured AF-MSCs express on their surface HLA-DR, 
CD 34, CD73, and CD90 and the percentages of 
positivity were calculated. 
  
 Osteogenic differentiation of AF-MSCs  
Osteogenic differentiation of AF-MSCs 
performed on the 3D scaffold of 10 mm diameters and 
3 mm heights in vitro. 3D Scaffold was used as a 
carrier for AF-MSCs, placed in 6-well culture plates, 
washed 3 times with 70 % ethanol, exposure to U.V 
for an hour and then washed twice with osteogenic 
medium (an hour for each rinse). AF-MSCs were 
seeded on the 3D scaffold at a density of 10x10
6
 and 
incubated at 37°C in osteogenic differentiation 
medium, DMEM containing 20% FBS, 100 μg/ml 
penicillin & streptomycin and 1% glutamax, L-ascorbic 
acid 2-phosphate, β-glycerol phosphate and 
dexamethasone for two and three weeks [16]. The 
scaffold carrying osteogenic differentiated AF-MSCs 
cells was fixed at 21
st
 day using Glutaraldehyde and 
analysis by scanning electron microscope (SEM) [19]. 
 
 In vivo study 
 The in vivo study, transplantation of human 
amniotic fluid stem cells (hAF-MSC) at the third 
passage (P3) was seeded on the 3D scaffold, 30% 
Nano-hydroxyapatite chitosan, and osteogenically 
differentiated for 3 weeks in osteogenic media and 
then applied to the induced tibia defect in the rabbit.  
 
 Ethics Approval  
 Ethical approval for this study was obtained 
from the National Research Centre Ethics Committee 
(approval number/16/263). 
 
 Animals and experiment design 
 A total of ten, six-month-old New Zealand 
White rabbits (1.5 – 2 Kg) were used for this study. 
Rabbits were classified into 3 groups as follows; G1: 
included 4 rabbits and were sacrificed at 2 weeks 
post-transplantation, G2: included 2 rabbits and were 
sacrificed at 3 weeks post-transplantation, and G3: 
included 4 rabbits and were sacrificed at 4 weeks of 
post-transplantation (Table 1). The defect has been 
transplanted with osteogenic differentiated hAF-MSCs 
progenitors cells seeded on the 3D scaffold in vitro 
(considered as an experimental target), and the tibia 
defect received 3D scaffold without osteogenic 
differentiated hAF-MSCs cells (considered as the 
control). 
Table 1: Animal Groups Classification 
Groups G1 G2 G3 
Rabbits no. 4 2 4 
Sacrificed/Post-operation  2 weeks 3 weeks 4 weeks 
 
Preoperatively, each rabbit has fasted for 12 
hours. General anaesthesia was induced by 
intramuscular injection of ketamine hydrochloride (35 
mg/kg BW) and xylazine (5 mg/kg BW) and 
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maintained throughout the surgical procedure. 
The external incision in the tibia, the skin 
incisions (approximately 1.5 cm) were carried out 
(initiated) and extending to the muscles layers deep to 
the bone level, producing a defect cavity in the tibia 
0.5 mm in diameter and 0.5 mm in depth. The cavities 
were prepared using standard round bur in a contra-
angle handpiece running at approximately 10,000 rpm 
and abundantly irrigated with saline solution. Finally, 
the flaps were repositioned carefully and sutured in 
layers. Postoperative pain was managed by injection 
of buprenorphine (50 μg/kg BW) at every 2 hours for 
the first day. This experiment was conducted following 
the national and European guidelines for animal 
experiments.  
The hAF-MSCs (approximately 2 million cells) 
at the third passage (P3) were seeded on the 3D 
scaffold, 30% Nano-hydroxyapatite chitosan, for two 
days in regular proliferation media and then replaced 
by osteogenic differentiation media after PBS 
washing, and incubated for 3 weeks at 37 ºC. 
Scanning electron microscope (SEM) was assessed 
to evaluate the osteogenic differentiation potential of 
hAF-MSCs osteogenic differentiated cells seeded on 
the 3D scaffold, 30% Nano-hydroxyapatite chitosan, in 
vitro. Meanwhile, osteogenic differentiated hAF-MSCs 
cells seeded on the 3D scaffold, 30% Nano-
hydroxyapatite chitosan, was applied and fitted in the 
defect area of rabbit tibia to evaluate the new bone 
formation and bone healing impact. 
 
 Histological examination 
Bone samples were fixed in 10% buffered 
formalin. Samples were decalcified in 0.5 M EDTA, pH 
8.3 (Sigma-Aldrich, St. Louis, MO, USA). Parietal 
bones were then rinsed in PBS, dehydrated with 
graded ethanol, and embedded in paraffin. 
Transversal serial sections 5-6 μm thick were 
deparaffinized in xylene, hydrated with a series of 
graded ethanol, stained with hematoxylin/eosin (H&E), 
and examined under the optical microscope (CX41, 
Olympus, Tokyo, Japan) [20].  
 
 Preparation of Nano-hydroxyapatite   
Artificial HA was prepared in the laboratory 
using the sol-gel method with an atomic ratio of Ca/P 
= (1.67) and pH = (10). Firstly, dissolving of 37.8 gm 
of calcium nitrate tetrahydrate in 1000 ml bi-distilled 
water. Meanwhile, 12.66 gm of diammonium hydrogen 
orthophosphate were also dissolved in another 1000 
ml bi-distilled water containing polyethylene glycol as 
a dispersant agent. The required amounts of both 
stock solutions to give the desired Ca/P atomic ratio of 
1.67 were mixed in room temperature, and the pH of 
the resulted mixture was adjusted to about 10 by the 
addition of a dilute NH4OH solution with proper 
strength. The above stapes were followed by ageing 
and vigorous stirring of the obtained solution at its 
boiling point for about 2 h in a sealed container. The 
HA was collected from the solution by filtration and 
was washed three times with bi-distilled water, 
followed by drying at 100
o
C overnight. A calcination 
temperature above 800
o
C was applied to the dried 
powder to eliminate the other impurities such as 
nitrates and ammonia. The particle size and the 
morphology of the prepared HA were determined 
using TEM. 
 
 Preparation of scaffold Nano-composites 
Acetic acid was used as the solvent to 
prepare the polymer solutions. By using 2 v % acetic 
acid solution, chitosan was dissolved using magnetic 
stirrer for 3 h, and the polymer solution was left 
overnight at room temperature to remove the air 
bubbles trapped in the viscous solution. Afterwards, 
30% of hydroxyapatite was dispersed in bi-distilled 
water by 30 min ultrasonic treatment. The dispersed 
HA powders were mixed with the chitosan solution 
under agitation. The homogeneously mixed solution 
was poured in a syringe which was used as cylindrical 
moulds and immediately taken to deep freeze at –
20
o
C. After 24 h freezing the samples were quickly 
lyophilised for 36 hours. Finally, the scaffolds were cut 
into discs and analysed by XRD, and SEM-EDX 
measurements before in vitro and in vivo studies. 
 
 Transmission Electron Microscope 
The morphology and particle size of the 
prepared hydroxyapatite was analysed using 
transmission electron microscope-TEM (JEM2010, 
Japan) working at 200 kv. Practically, 10 mg of HA 
powder was dispersed ethanol using the ultrasonic 
bath, and few drops of prepared suspension were 
dropped on the Cu grid. Afterwards, the grid was left 
to dry at room temperature and was further 
investigated by the TEM. 
 
 X-ray diffraction analysis (XRD) 
X-ray diffraction analysis (XRD) was used to 
identify the phase of the prepared samples. The data 
was collected from a (Diano corporation made in the 
USA) diffractometer using monochromatic CuKα 
radiation (λ=1.5406Å) with scanning rate 0.1
o
 in the 
2θ ranging from 10 to 80
o
 step radiation. Voltage and 
current were set at 40 kV and 40 mA, respectively. 
 
 Scanning Electron Microscope  
The scaffold microstructure was studied using 
JSM 6360 LV SEM (JEOL, Japan). In detail, the 
cross-sectional view for the prepared scaffold was 
studied through mounting the internal scaffold 
structure on metal stubs and was coated with gold 
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before being examined. Additionally, X-ray elemental 
analysis (EDAX) was carried out for the samples pre- 
in vitro and in vivo studies to assess the presence of 
the inorganic elements within the examined scaffold. 
Moreover, SEM images were recorded for the 
scaffold with and without hAF-MSCs osteogenic 
differentiated cells in vitro and in vivo to evaluate the 
effect of the combination of hAF-MSCs osteogenic 
differentiated cells and scaffold on bone healing rate. 
Practically, in vitro SEM images were obtained upon 
seeding of hAF-MSCs on the scaffold surface in 12 
well plates for 21 days in the osteogenic media. In 
details, the scaffolds were washed 3 times with 70 % 
ethanol, exposed to U.V light for 2 h, and then washed 
twice with the culture medium. 
 
 
Results 
 
 Proliferation and culture expansion of 
 hAF-MSCs 
 
Figure 1: Proliferation and culture expansion of hAF- MSCs at 
different passage. (A & B) P0 at 7 & 21 days respectively; (C&D) P1 
at 7 &17 days respectively; (E&F) P2 at 7 &19 days respectively; 
(G&H) P3 at 7 & 21 days respectively, magnification X10 
 
Human AF-MSCs was cultured and expanded 
in regular proliferation media. Colonies of hAF-MSCs 
appeared in the primary culture (P0) after 7-10 days 
from the initial cell plating day. Cells aggregated from 
central to peripheral side of the plate till reaching 75% 
confluence by the end of this passage (Figs. 1A, B 
respectively). At the beginning of the first passage 
(P1), hAF-MSCs displayed typical fibroblast-like cells 
morphology and presented a higher proliferation rate 
by the end of this passage (Figs. 1C, D respectively). 
Human AF-MSCs presented typical mesenchymal cell 
morphology in the subsequent passages and 
experienced further proliferation and expansion in the 
second passage (P2) (Figs. 1E, F) and third passage 
(P3) (Figs. 1G, H).  
 
 Osteogenic differentiated AF-MSCs on 14
th
 
 and 28
th
 days 
 
Figure 2: Alizarin red staining of osteogenic differentiated AF-MSCs 
on 14 and 28 days, A) Control at 14 days  of culture showed no red 
staining; B) Osteogenic differentiated AF-MSCs cells at 14 days 
showed few stain spots in centre of the plate; C) moderate red 
staining patches were detected in peripheral side of the plate; D) 
Control at 28 days of culture showed very weak red staining spots; 
E) Strong red staining patches of osteogenic differentiated AF-
MSCs at 28 days in the central of the plate; F) Stronger red staining 
intensity of osteogenic differentiated AF-MSCs cells in peripheral 
side of the plate 
 
 Osteogenic differentiation of hAF-MSCs 
 seeded on Scaffold after three weeks in 
 vitro 
The hAF-MSCs cells were seeded and 
osteogenically differentiated on the 3D scaffold, Nano-
hydroxyapatite chitosan, in the osteogenic media for 3 
weeks in vitro, small to large black areas represented 
scaffold filled with AF-MSCs osteogenic differentiated 
and calcium deposits all over the plate were observed 
using an inverted microscope (Figs. 3A & B). 
Moreover, this finding was confirmed by using the 
electron microscope scanned (EMS) indicating the 
osteogenic differentiated hAF-MSCs was penetrated 
the pore and filled with calcium nodule deposits which 
will be ready for animal transplantation, bone repair, 
and regeneration (Fig. 3D) compared to the non-
seeded scaffold (Fig. 3C). 
 
 
Basic Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
2744                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
 
Figure 3: Osteogenic differentiation of hAF-MSCs seeded on 
Scaffold after 3 weeks in vitro. (A) & (B) Osteogenic differentiated of 
hAF-MSCs seeded on scaffold represented by inverted microscope 
images. (C) Non-seeded Scaffold (SEM, Scale Bar: 100 µm); (D) 
hAF-MSCs osteogenic differentiated seeded on the scaffold (SEM, 
Scale Bar: 500 µm) 
 
 Flow cytometric analysis 
Flow cytometric analysis was performed to 
detect the AF-MSCs immunophenotypes.  
Table 2: Flow-cytometry parameters in hAF-MSCs 
Positivity rate hAF-MSCs Surface marker 
42.1% CD73 
2.4% CD90 
0.2% CD34 
0.1% HLA-DR 
 
The percentage were positive for both CD73 
and CD90 cell surface markers showed 42.1 % and 
2.4% respectively, while were negative for both CD34 
and HLA-DR cell surface markers showed 0.2%, and 
0.1% respectively (Table 2) (Fig. 4). 
 
Figure 4: Flow cytometric analysis for hAF-MSCs.  (A) & (B) hAF-
MSCs were positive for both CD73 and CD90 cell surface markers 
42.1% & 2.4% respectively. (C) & (D) hAF-MSCs were negative for 
both CD34 and HLA-DR cell surface markers 0.2% & 0.1% 
respectively 
 Histological results 
At two weeks post-transplantation, histological 
examination of sections transplanted with osteogenic 
differentiated hAF-MSCs cells seeded on the 3D 
scaffold, 30% Nano-hydroxyapatite chitosan, showed 
large areas of newly formed bone that were observed 
directly nearby to the host bone as compared to the 
control (Fig. 5A). In contrast, the control (non-seeded 
scaffold) showed areas filled with structurally and 
morphologically rearranged fibrous tissue consistent 
with the failure to repair the bone defect (Fig. 5B). 
A
 
B
 
C
 
D
 
E
 
F
 
Figure 5: Histopathological Sections of rabbits transplanted by hAF-
MSCs and Scaffold. A): Osteogenic differentiated hAF-MSCs 
seeded on the 3D scaffold, 30% Nano-hydroxyapatite chitosan after 
2 weeks showing large areas of new bone formation visible 
immediately nearby to the host bone compared with the control 
(non-seeded scaffold). Notice the occurrence of an infinite network 
of vessels is obviously in the not yet mineralized construct area, B) 
Control, after 2 weeks showing areas filled with structurally and 
morphologically prearranged fibrous tissue consistent with failure to 
repair the bone defect; C) hAF-MSCs/scaffold, after three weeks 
shows large areas of mature formed in the defect. Few vacuoles 
filled with collagen were noticed D) Control after 3 weeks shows 
limited bone regeneration and large bone defect remaining. Notice 
that the defect is filled primarily with connective tissues; E) hAF-
MSCs/scaffold after 4 weeks show large mature bone mostly filed 
the whole defect. Few vacuoles filled with collagen were noticed; F) 
Control after 4 weeks shows limited bone regeneration and large 
bone defect remaining. Notice that the defect is filled primarily with 
connective tissues (H&E stain; Scale bar: 20 µm) 
 
At three weeks post-transplantation, sections 
of bone defect transplanted with osteogenic 
differentiated hAF-MSCs/scaffold showed large areas 
of mature formed bone in the defect site. Few 
vacuoles filled with collagen were noticed as 
compared to control one (Fig. 5C). However, the 
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control (non-seeded scaffold) showed limited bone 
regeneration with a large bone defect area remaining. 
The defect was filled primarily with connective tissues 
(Fig. 5D). 
At four weeks post-transplantation, 
histological examination of bone sections defect 
transplanted with osteogenic differentiated hAF-
MSCs/scaffold showed mature bone formation mostly 
filled the whole defect area. Few vacuoles filled with 
collagen were noticed (Fig. 5E). However, the control 
(non-seeded scaffold) showed limited bone 
regeneration and large bone defect area remaining. 
Notice that the defects were filled mainly with 
connective tissues (Fig. 5F). 
 
 Morphology of the prepared Nano-
 hydroxyapatite  
The morphology and the size of the prepared 
Nano-hydroxyapatite were evaluated by TEM as 
represented in Fig. 6. The Nano-hydroxyapatite 
particles are presented in the nanoscale with a range 
of 20-30 nm. Semisphere morphology was observed 
for aggregated particles of hydroxyapatite.  
 
Figure 6: TEM image of the prepared Nano-hydroxyapatite (TEM, 
Scale Bar: 100 µm) 
 
 Scanning Electron Microscope results 
The XRD technique is employed to assess 
the phase purity, the level of crystallinity and changes 
of the prepared nanocomposites. XRD method is 
based on the coherent scattering of X-rays by an 
ordered lattice, in this case, a crystal in which the 
atoms are periodically ordered. Interference of the 
radiation with the crystal lattice leads to a distinct 
distribution of diffracted intensity as a function of the 
measuring angle 2θ.Fig.7a shows the X-ray diffraction 
pattern of the prepared hydroxyapatite (HA). Several 
peaks were observed at approximately 25.8°, 29.1, 
30.6° and 31.8°C, these peaks are corresponding to 
the diffraction planes (211), (002), (210) and (300) of 
the hydroxyapatite (HA) crystallites, respectively, that 
confirms the formation hydroxyapatite as early 
reported [21, 22]. It is worthy noted that upon the 
formation of chitosan/hydroxyapatite composite 
scaffold, no remarkable changes were observed for 
the crystallisation of the HA particles. However, minor 
crystallisation decrease was noted (Fig.7b). In 
addition to that, the characteristic crystalline peaks of 
HA were significantly shifted, due to the expected 
interface binding that takes place between 
hydroxyapatite particles and chitosan matrix. 
 
Figure 7: XRD analysis of a) the prepared Nano-hydroxyapatite and 
b) chitosan /hydroxyapatite composite scaffold 
 
 The scanning electron microscope (SEM-
EDX) micrographs of the prepared scaffold composite 
(HC30) is shown in Fig. 8. The SEM images provide 
direct information about the mullet-porous structure of 
the as-prepared hydroxyapatite/chitosan scaffold 
nano-composite. SEM images demonstrated a large 
number of pores around the size of 200 µm–700 µm. 
These pores are connected to form an interconnected 
porous network. The rough surface that was observed 
for prepared composites was attributed to the 
incorporation of hydroxyapatite in the composite. The 
HA particles were embedded well in the chitosan 
matrix. From the EDX spectra of the prepared 
hydroxyapatite /chitosan scaffold nanocomposite (Fig. 
8), illustrated the recorded elements within the 
investigated scaffold as following; Ca, P, C and O. 
 Furthermore, the cells attachment on the 
scaffold surface cultured in the osteogenic medium at 
culture time 21 days (Fig. 9a), was also investigated 
using SEM. “C” corresponds to cells, “J” is the cell-cell 
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junctions, “M” mineralisation is also detected. 
Extracellular matrix (EX), attached to scaffold surface, 
of chitosan /hydroxyapatite composite scaffold. 
 
Figure 8: Illustration of a) SEM image for the microstructure (Scale 
Bar: 100 µm) and b) EDX elemental analysis for the chitosan 
/hydroxyapatite composite scaffold 
 
In details, it is very clear that human amniotic 
fluid-derived stem cells (hAF-MSCs)are grown on 
scaffold surface and have displayed an elongated 
shape and spread out discretely within the pores and 
on the surface of the scaffold.  
Also, mineral aggregates formation was noted 
after 21 days of culture, thus denoting the osteogenic 
activity of prepared scaffold. The higher magnification 
image (Fig.9b) that show the surface of the cells on 
prepared scaffolds appeared to be smoother than that 
on the scaffolds, indicating greater extracellular matrix 
(EX) depositions and fibrous networks on scaffolds 
surface as well as attached cells. 
In addition to that, the in vivo bone healing 
was investigated by using SEM (Fig.10). Post-
transplantation of the prepared scaffold was 
transplanted into the rabbit's tibia defect, revealed 
normal healing of the bone tissues with no 
abnormalities over the site of the operation. 
 
Figure 9: SEM images of a) chitosan/hydroxyapatite composite 
scaffold and b) Zoom in mineralisation on the scaffold surface 
(SEM, Scale Bar: 50 and 5 µm, respectively) 
 
 
All rabbits were healthy and did not present 
signs of oedema during the post-transplantation 
period. The scaffolds were in direct contact with new 
bone without any fibrous encapsulation and almost 
completely covered with new bone (NB) indicating that 
scaffolds were highly bioactive as well as 
biocompatible. 
Few remains of scaffolds were still found in 
the defect, as well as unfilled margins (Figs.10a 
&10c). They were in direct contact with new bone 
without any fibrous encapsulation and almost 
completely covered with bone indicating that scaffolds 
were highly bioactive as well as biocompatible. The 
induced bone defect in the rabbit tibia transplanted 
with the non-seeded scaffold at two and four weeks 
post-transplantation was semi-healed with highly 
mineralised bone matrix, and the defect holes remain 
semi-opened (Figs. 10a & 10c). 
For the defect transplanted with osteogenic 
differentiated hAF-MSCs/scaffold at 2 weeks post-
transplantation (Fig. 10b), new bone formation 
progressed from the deep end walls of the defect 
regions in-wards. Complete bone integration was 
detected for the transplanted osteogenic differentiated 
hAF-MSCs/scaffold at 4 weeks post-transplantation 
(Fig.10d).  
The new bone was formed in continuity with 
the transplant surface from the cortical bone at the 
defect site into the marrow space. Also, the results of 
SEM made for the non-seeded scaffolds transplanted 
in vivo revealed that the bioactive degradable 
scaffolds have a great response with the host bone 
and the remodelling proceeded at the scaffolds-bone 
interface. The induced bone defects in the rabbit tibia 
at 4 weeks post-transplantation were completely 
closed by mineralised (M) bone matrix, collagen fibres 
(CF) and differentiated cells (DC) (Fig. 10 d). There 
was evidence of new bone formation on the surface of 
all implants with no evidence of fibrous encapsulation. 
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Figure 10: SEM images of chitosan/hydroxyapatite composite 
scaffold after in vivo implantation. a) control, non-seeded Scaffold 
after 2 weeks, b) osteogenic differentiated hAF-MSCs cells seeded 
on Scaffold after 2 weeks, c) control, non-seeded Scaffold after 4 
weeks and d) osteogenic differentiated hAF-MSCs cells seeded on 
Scaffold after 4 weeks (SEM, Scale Bar: 100 µm) 
 
 
 
Discussion  
 
Human amniotic stem cell (hAF-MSCs) has a 
high proliferative capacity and osteogenic 
differentiation potential in vitro provides a very 
promising source for bone repair applications. 
Moreover, the combination of hAF-MSCs and three-
dimensional (3D) scaffold is considered to be a 
promising approach for therapeutic purpose 
applications in bone tissue engineering and 
regenerative medicine. 
In our previous study, results revealed the 2
nd
-
trimester hAF-MSCs used in repairing the induced 
spinal cord defect in rat model had the priority of bone 
healing efficiency compared to both the 3
rd
-trimester 
hAF-MSCs and hBM-MSCs transplanted into the 
same animal model [23]. Accordingly, we suggested 
that the 2
nd
-trimester hAF-MSCs cells may represent a 
valuable healing prospect in combination with 3D 
scaffolds for bone regeneration in the rabbit tibia 
defect. 
The assessment of the combination of the 2
nd
-
trimester hAF-MSCs with the 3D scaffold, 30% Nano-
hydroxyapatite chitosan, in our study demonstrated 
the osteogenic induction for three weeks in vitro; cells 
penetrated the scaffold porous, filled with calcium 
deposited and were ready for repairing the bone 
defect in a rabbit model. This finding is consistence 
with Maraldi et al., who conducted his study on a rat 
model. They support the idea of the efficiency of 
scaffold material, fibroin, combined with AF-MSCs in 
healing critical-size bone defects [24]. Our hAF-MSCs 
subjected an osteogenic differentiation in vitro for 21 
days on the 3D scaffold, 30% Nano-hydroxyapatite 
chitosan, showed great mineralisation and repairing 
potential for the induced bone defect in the rabbit. 
Interestingly, Peister et al. demonstrated that AF-
MSCs have the effect to differentiate for 28 days on 
3D medical-grade poly-e-caprolactone (mPCL) 
scaffolds in vitro producing seven times more 
mineralised matrix when transplanted subcutaneously 
in the rat model. Findings of this study suggest that 
AF-MSCs could be an effective cell source for efficient 
repair of large bone defects [25]. 
However, our in vivo study revealed the 
combination of osteogenic differentiated hAF-MSCs 
cells and scaffold enhanced the bone healing 
efficiency in the bone defect of rabbit at 4 weeks post-
transplantation comparing to the control (non-seeded 
scaffolds). Roccio et al., in 2012, carried out a 
comparative assessment of fibroin scaffolds combined 
with human dental pulp stem cells (hDP-MSCs) and 
amniotic fluid stem cells (hAF-MSCs) for repairing the 
cranial bone defects in immunocompromised rats [26]. 
They reported a significant efficient healing property of 
the combination of stem cells/fibroin bioengineered 
scaffold in repairing large animal cranial defects. This 
finding could be a starting point for human large bone 
defects regeneration in craniofacial surgery [26]. 
Moreover, Kim et al., have already noted an 
inconsistency with Roccio`s results that hAF-MSCs 
seeded on another type of 3D scaffold, collagen 
matrix extracted from porcine bladder submucosa 
matrix (BSM) and poly (lactide-co-glycolide) (PLGA),  
offered an appropriate microenvironment that 
enhanced osteogenic differentiation of hAF-MSCs in 
vitro and could be used in bone tissue engineering 
[27]. 
In the present study, AF-MSCs were 
examined for surface and differentiation markers 
percentages on cells using flow cytometer as an 
indication of Mesenchymal stem cells (MSC). Flow 
cytometric assays were performed within the tested 
cell population for CD34, CD90, and CD73 in addition 
to HLA-DR. Isolated AF-MSCs cells in this study 
revealed moderate expression of CD73 (42.1%) in 
addition to the negativity of CD34 and HLA-DR (0.2% 
and 0.1 %respectively) and weak expression of CD90 
(2.4%). Regarding CD34, our results came by De 
Rosa et al., and Fei et al., studied the phenotypic 
characterisation of AF-MSCs [28, 29]. By flow 
cytometric assays; found them negative for CD34. 
Moreover, our results also agreed with Zhou et al., 
stated that AF-MSC must express CD105, CD73 and 
CD90 and lack the expression of CD45, CD34, CD14, 
CD11b, CD79a, CD19 and HLA-DR surface 
molecules. In the same context, in this study, CD73 
was positively expressed (42.1%); while CD34 and 
HLA-DR were negatively expressed (0.2% and 0.1% 
respectively); results of which had the same opinion 
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as Markmee et al., found CD73 (49.85%), CD34 
(0.3%) and HLA DR (0%) [30].  
Nevertheless, Spitzhorn et al. found that AF-
MSCs obtained during C-sections showed the typical 
MSC cell surface marker expression of CD73, CD90, 
and CD105 by the parallel absence of the 
hematopoietic markers CD14, CD20 and CD34 [31]. 
The analysis of the isolated cells in Fei et al., study, 
revealed negative expression of the hematopoietic 
stem cell marker, CD34 and some cells were weakly 
positive for MHC Class II antigens (HLA-DR and HLA-
DQ) [29], which agree with the results found in the 
present study.  
Additionally, regarding, HLA-DR testing, cells 
were found negative as the previous results of Zhou et 
al., [32]. However, our study didn't reveal strong 
positivity for CD90, unlike Zhou et al., Savickiene et 
al., and Markmee et al. [30], [32], [33]. On the 
contrary, Fei et al. found isolated cells in his study not 
expressing markers of hemopoietic lineage such as 
CD105 (SH2), CD70 (SH3/4), CD29, CD16, CD44, 
and CD90 [29]. 
The analysis of our histopathological results 
revealed a distinctive increase in bone regeneration in 
the tibia defect of a rabbit when received the 
osteogenic differentiated hAF-MSCs cells/scaffold 
composite system which mostly filled with mature 
bone and few vacuoles filled with collagen at 4 weeks 
post-transplantation. However, the control (non-
seeded scaffold) presented fewer, smaller mineralised 
tissue, limited new bone formation, and there was a 
large bone defect area still not filled with bone. These 
findings identified the highest bone healing efficiency 
with complete healing of the bone defect at 4 weeks 
post-transplantation. However, the least bone healing 
potential was observed at 2 weeks post-
transplantation; these findings were consistency with 
the Scanning electron microscope (SEM) results. 
There is a satisfactory agreement between our results 
and those of Rodrigues et al., despite the difference in 
scaffold type, transplantation time, an animal model 
[34]. 
It is well known that hydroxyapatite mineral 
forms about 70 wt. % of natural bone. Collagen and 
water represent the remaining portion (20-30) wt. %. 
Nano-structured hydroxyapatite crystals are aligned 
along the collagen fibres within the water phase [35]. 
Herein, the prepared hydroxyapatite possessed 
similar morphology and particle size for those of the 
natural bone. The XRD results for the prepared 
scaffolds revealed that incorporation of the Nano-
hydroxyapatite didn't alert the physical stability and 
crystalline nature of obtained scaffold. The low 
crystallinity of the obtained HA that was much similar 
to the apatite in natural bone could improve the 
biodegradability (Fig. 7). It is well known that bone 
biological characterises of scaffolds are affected by 
their chemical composition, crystallinity, crystal 
orientation and porous structures [36].  
SEM images revealed the scaffolds would 
allow the attachment and spreading of the cells while 
keeping a normal cellular morphology as confirmed 
with recorded pore sizes (200 µm – 700 µm). These 
pores are associated with each other to form an 
interconnected porous network. This network directly 
facilitated the normal activity of the cells such as 
nutrition transport, ions exchange and elimination of 
the cells biological leftover. Porous structure enables 
the cells infiltration within the pore cavities and 
provides enough nutrition and blood supply through 
penetration and circulation [37], [38]. 
It is worth to highlight that the choice of 
scaffold depends on the specific tissue to be 
engineered. It is generally recognised that the 
chemical properties of materials can influence the 
cellular behaviour of osteoblasts [12], [39]. SEM 
images for the current investigated scaffold suggested 
that the 30 CH scaffold of higher support osteogenic 
activity and these results were in the same line with 
early reported studies [12], [39].   
Chitosan-nanocomposite scaffolds, the 
biomaterials that were utilised in the current research, 
are deemed osteoconductive materials to both cell 
adhering and tissue ingrowth, and it couples 
biomaterial resorption with bone formation [40], [41]. 
However, The SEM images of hAF-MSCs seeded on 
the 3D scaffold, 30% Nano-hydroxyapatite chitosan, 
have demonstrated a higher healing potential 
compared to the control, non-seeded scaffold, 30% 
Nano-hydroxyapatite chitosan at 2 and 4 weeks post-
transplantation. 
Our investigations into this area are still 
ongoing, and further investigations on studying 
different stem cell sources as well as various scaffold 
materials will advance our knowledge about the 
contribution of stem cells progenitor and scaffold 
composite system to the field of bone tissue 
engineering.  
In conclusion, based on our in vitro and in 
vivo findings, we suggest that the 2
nd
-trimester hAF-
MSCs in combination with the 3D scaffold, 30% Nano-
hydroxyapatite chitosan, could significantly promote 
and enhance the bone healing efficiency in the rabbit 
model. Furthermore, this approach can be used as an 
outstanding system for functional bone treatment for 
the repair of large bone defect in human, bone tissue 
engineering and regenerative medicine.  
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